Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Expert Review of Anti-Infective Therapy
|
February 10, 2015
Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections
Gary Wu, James Truong, Spencer Lee, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 20, 2021
Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients
John J Veillette, S Alexander Winans, Victoria K Maskiewicz, et al.
Journal of Clinical Pharmacology
|
September 20, 2021
Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics
Yoonsun Mo, Natalia Shcherbakova, Kelsey L Inman, et al.
Open Forum Infectious Diseases
|
May 16, 2020
Early Experience With Eravacycline for Complicated Infections
Sara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2022
Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study
Samuel P Simon, Rosanna Li, Michael Silver, et al.
Diagnostics (Basel, Switzerland)
|
June 13, 2025
Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection
Hui Li, Dakai Liu, Qiang Zhou, et al.
Infectious Diseases and Therapy
|
January 27, 2020
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Sarah C J Jorgensen, Kyle P Murray, Abdalhamid M Lagnf, et al.
Microbiology Spectrum
|
October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Microbiology Spectrum
|
August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Expert Review of Anti-Infective Therapy
|
February 10, 2015
Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections
Gary Wu, James Truong, Spencer Lee, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 20, 2021
Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients
John J Veillette, S Alexander Winans, Victoria K Maskiewicz, et al.
Journal of Clinical Pharmacology
|
September 20, 2021
Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics
Yoonsun Mo, Natalia Shcherbakova, Kelsey L Inman, et al.
Open Forum Infectious Diseases
|
May 16, 2020
Early Experience With Eravacycline for Complicated Infections
Sara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2022
Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study
Samuel P Simon, Rosanna Li, Michael Silver, et al.
Diagnostics (Basel, Switzerland)
|
June 13, 2025
Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection
Hui Li, Dakai Liu, Qiang Zhou, et al.
Infectious Diseases and Therapy
|
January 27, 2020
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Sarah C J Jorgensen, Kyle P Murray, Abdalhamid M Lagnf, et al.
Microbiology Spectrum
|
October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Microbiology Spectrum
|
August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Page
of 3